For decades, d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), a derivative of vitamin E, has been a cornerstone in oral drug…
Read More
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market Impact
Japan’s latest National Health Insurance (NHI) drug price revision for Fiscal Year 2026 (FY26) has officially taken effect, ushering in…
Read More
Pioneering Unconventional Drug Delivery Systems Transform Cancer Treatment Landscape
The effectiveness of groundbreaking therapeutic agents is intrinsically linked to their successful and precise delivery within the human body. Without…
Read More
Daiichi Sankyo Partners with Waiv to Accelerate Digital Pathology Biomarker Discovery for Antibody-Drug Conjugate Programs
In a strategic move to enhance precision in oncology drug development, Japanese pharmaceutical giant Daiichi Sankyo has announced a significant…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…
Read More
From list price to net price: How finance leaders decode real drug costs
In the complex tapestry of the healthcare industry, discussions surrounding drug pricing frequently commence and conclude with the list price.…
Read More
Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery
Researchers in China have achieved a significant breakthrough in ophthalmic pharmacology, developing innovative eye drops derived from pig semen that…
Read More
The Joint Clinical Assessment: Navigating Procedural and Methodological Hurdles in EU Drug Evaluation
The advent of the Joint Clinical Assessment (JCA) process in the European Union, designed to harmonize the clinical evaluation of…
Read More
AMSBIO Unveils Advanced Quick-Glia™ iPSC Differentiation Kits, Revolutionizing Neurobiology and Drug Discovery for Human Glial Cells
AMSBIO, a global leader in life sciences solutions, has significantly expanded its portfolio of induced pluripotent stem cell (iPSC) Differentiation…
Read More
Eli Lilly Soars Past Expectations on Unabated Weight-Loss Drug Demand, Raises Full-Year Forecast
Eli Lilly and Company has once again demonstrated its formidable market power, reporting first-quarter 2026 sales that significantly surpassed analyst…
Read More
